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The role of ultrasound in the evaluation of the endome-
trium has been overshadowed by a large volume of lit-
erature about the ovaries and myometrium. In fact, aside
from some investigations centering on the thickness of
the endometrium in the normal woman and its relation-
ship to the possibility of endometrial cancer, there has
been little interest in the endometrium until very recently.
Transvaginal sonography (TVS) has provided a modest
improvement over transabdominal sonography (TAS) to
image the endometrium and evaluate pathology; how-
ever, the gynecologic community relies heavily on en-
dometrial biopsy (EMB), dilatation and curettage (D&C),
and hysteroscopy for endometrial diagnosis.
The introduction of saline-infused hysterosonogra-
phy (HSG) has revolutionized gynecologic ultrasound of
the endometrium. The variety and frequency of endo-
metrial disorders seen with HSG rivals and even sur-
passes that seen with hysteroscopy, a moderately inva-
sive procedure. This article will attempt to define the role
of ultrasound in the complex anatomy, physiology, and
pathology of the endometrium.
Techniques
Transabdominal sonography
Many sonologists insist on performing TAS as a screen-
ing procedure prior to performing any other ultrasound
techniques such as TVS or HSG. TAS requires a full
bladder and is often uncomfortable and time-consum-
ing, particularly in the postmenopausal woman. For spe-
cific evaluation of the endometrium in the patient with
a normal-sized uterus, TAS is unnecessary as the first
step [1–3]. Furthermore, as the patient becomes well
hydrated to fill her bladder for TAS, a partially full blad-
der interferes with TVS and HSG, which are best per-
formed with the bladder completely empty [4].
When the uterus and ovaries are incompletely vi-
sualized on TAS, it may the be appropriate to perform
TAS, but if the uterus is enlarged and anteverted, a full
bladder may not be necessary for visualization of the
myometrium and ovaries. The uterus can act as an
acoustic window.
Transvaginal sonography
Since its introduction in the mid-1980s, TVS has be-
come the standard way to image the female pelvis in
the gynecologic community and an important adjunct to
the radiologist/sonologist. End-fire endoluminal probes
of 5–9 MHz have been used. The patient, technologist/
sonographer, or sonologist can insert the probe. Imaging
is in the coronal or sagittal plane, and the endometrium
is well suited for this technique due to its proximity to
the vaginal apex, allowing for high resolution scanning
[1–5] (Fig. 1).
There is continuing interest in the role of spectral
and color Doppler imaging for the endometrium. Either
of these techniques may have a role in the differential
diagnosis of endometrial abnormalities and are available
as adjunctive techniques on most modern ultrasound
machines. As with other Doppler applications in the pel-
vis, there is considerable overlap of benign and malig-
nant abnormalities when measuring indices of resis-
tance, which, when decreased, suggest angioneogenesis
associated with neoplasms. Unfortunately, the normal
cyclic physiology of the female pelvis produces an-
gioneogenesis in both ovaries and uterus, making these
analyses difficult [2]. However, as will be discussed,
color Doppler may have a role in differentiating endo-
metrial polypoid lesions.
Hysterosonography
Although introduced as early as 1986 for potential eval-
uation of tubal patency, HSG has only recently become
popular as an important technique for endometrial eval-
uation [6–8]. In our department, the procedure is per-
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Fig. 1. Transvaginal examination of the normal uterus. A transvaginal
scan of the uterus is performed in a sagittal plane. The uterus is an-
teverted and an almost empty bladder (b) is seen just anterior to the
uterine fundus. Moderate prominence of myometrial vessels (*) is
seen between the middle and outer zones of the myometrium. The
cervix (C) and the endocervical canal (arrow) are clearly visible. The
patient is in the proliferative phase, and the endometrium (between
arrowheads) is hypoechoic. The endometrial canal (open arrowhead)
is clearly visible.
Fig. 2. HSG in premenopausal woman performed at mid-cycle. A Sag-
ittal transvaginal scan demonstrates prominent endometrium compat-
ible with secretory phase. B Following catheterization and installation
of fluid, HSG demonstrates normal endometrium with endometrial
layers separated by fluid. C Power Doppler image of the endometrium
during HSG demonstrates moderate vascularity compatible with se-
cretory endometrium.
formed following TVS or TAS and TVS, without sig-
nificant preparation. We use a lighted speculum and a
5-Fr balloon-bearing commercially available HSG cath-
eter (Ackrad Labs, Cranford, NJ).
The patient is placed in the lithotomy position, and
the speculum is inserted. The cervix is identified and
swabbed with iodine solution. A long cotton swab,
available in gynecology departments, is useful. The ex-
ternal cervical os is identified, and the outer stiffener of
the catheter system is placed as far into the os as pos-
sible. The catheter is then advanced, and the balloon
inflated with about 0.5–1 cc of saline, being careful not
to instill air, which can create an acoustic artifact. If
there is resistance to advancing the catheter, gentle pres-
sure may be applied, and the catheter will often advance
over what may be adhesions or areas of stenosis. Rarely,
it may be necessary to leave the catheter tip in the cer-
vical canal and inflate the balloon to prevent dislodg-
ment. TAS can be useful to monitor insertion in difficult
cases. In very difficult catheterizations, a tenaculum
may help stabilize the cervix, or a cervical dilator may
open the canal for catheterization. Alternative catheters
include urethral balloon catheters, insemination cathe-
ters, and pediatric feeding tubes [6–8]. The speculum
is then carefully removed without dislodging the cath-
eter. A speculum that disengages or has one open side
can facilitate this maneuver.
Following successful placement of the catheter into
the endometrial cavity, sterile saline is instilled with
transvaginal real-time ultrasound monitoring. Depend-
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ing on the patient’s age, uterine morphology, and pres-
ence of pathology, we instill 3–40 cc of saline. To pre-
vent leakage of fluid, it is helpful to put traction on the
catheter to seal the internal os with the balloon. The
catheter should be flushed with saline prior to insertion
so no air is instilled. Fluid instillation should be slow to
decrease the level of cramping. Some have suggested
preparation with ibuprofen to decrease cramping. Im-
ages are obtained just after balloon deflation and upon
removal of the catheter to image the lower uterine seg-
ment free of the catheter artifact. Antibiotics are not
routinely given after the procedure [6] (Figs. 2, 3).
In the premenopausal patient, HSG should be per-
formed in the proliferative phase of the menstrual cycle,
if possible, to help separate endometrial hyperplasia
from secretory endometrium. In the postmenopausal pa-
tient, timing of the exam is not as important unless the
patient is on cyclic hormonal replacement [7].
Normal anatomy and physiology
The premenopausal patient
The endometrium can be seen on TAS, TVS, and HSG.
Measurements of the endometrial thickness are best
made on TVS or HSG because of the proximity of the
transducer to the uterus. The measurement is best made
in the sagittal plane, and the convention is to use the
full thickness of the endometrium minus any fluid that
may be present [2, 3, 8] (Figs. 1, 3A, 4A, 5).
In the normal menstrual cycle, day 1 represents the
first day of menstrual flow. A scan performed on that
day may show fluid or blood clot in the endometrial
cavity (Fig. 5). The endometrium is thinnest on the last
day of flow, typically on days 3–5. Endometrial thick-
ness in the proliferative phase of the cycle (days 5–14)
is 2–8 mm. In the proliferative phase, the endometrium
is hypoechoic, with the lumen maintaining a thin hy-
perechoic appearance [9, 10] (Fig. 1). Occasionally, the
junctional zone between the endometrium and the inner
myometrium may appear hypoechoic to the inner zone
myometrium and may give the appearance of a halo [11]
(Fig. 1). Beginning at day 14, when many women ovu-
late, the secretory phase begins (Fig. 6). The endome-
trium becomes thicker, reaching a maximal thickness of
12 mm [9, 10]. Furthermore, the endometrium becomes
more echogenic due to the change in glandular content
from absence of secretions to glycogen and mucin [2,
10] (Figs. 2, 6). The boundary between the endometrium
and the inner myometrium again may be hypoechoic
and is termed the ‘‘junctional zone.’’ The exact histo-
logic correlate of this zone remains controversial, but it
is probably a compact inner layer of myometrium [11]
(Figs. 1, 4A, 6A).
In the premenopausal patient, HSG can provide ad-
ditional detail of the endometrial thickness and mor-
phology. The addition of color or power Doppler can
allow analysis of blood flow and resistance (Fig. 2).
The postmenopausal patient
Because most pathologic conditions of the endome-
trium occur during perimenopause and postmeno-
pause, there is much interest in the sonographic ap-
pearance in this group of patients. The major clinical
problem in this patient group is abnormal bleeding.
The amount and significance of the bleeding depends
on the presence and type of exogenous hormone re-
placement therapy (HRT).
Table 1 outlines the major forms of HRT and the
expected endometrial thicknesses for patients with and
without HRT. In the patient without HRT, an endome-
trial thickness greater than 5–6 mm may be abnormal,
particularly at 5 years postmenopause and beyond, and
the asymptomatic patient may require, at minimum, a
follow-up examination. In patients with HRT, endo-
metrial thickness may approach that seen during pre-
menopause, particularly for those women on cyclic
therapy and those less than 5 years from the onset of
menopause. As with the premenopausal population,
HSG may be extremely useful for confirmation of nor-
mality or for defining pathology [4–8, 12, 13] (Figs. 3,
7, 8).
Clinical problem solving with ultrasound
Screening for endometrial cancer
There is considerable debate in the literature about the
value of screening for endometrial cancer in the asymp-
tomatic patient. Osmers et al. [14] argued that a detec-
tion rate of 3.5% when screening asymptomatic women
makes screening a worthwhile investment. Unfortu-
nately, like screening for prostate cancer, screening for
endometrial cancer has not been subjected to rigorous
cost–benefit analysis, taking into account the lead time
bias that is present in any screening situation. Is there
any data to indicate that an earlier diagnosis of endo-
metrial cancer affects the cure rate and survival? Would
not most of these patients eventually present with ab-
normal uterine bleeding, particularly those in post-
menopause [15]?
If screening for endometrial cancer were to be found
economically feasible, the data suggest that an endo-
metrial thickness of 4 mm or less in the asymptomatic
postmenopausal patient would exclude all cases of en-
dometrial cancer [14]. In premenopausal patients, there
is no role for screening for endometrial cancer.
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Fig. 3. Normal HSG in patient on HRT with continuous estrogen
and progesterone. A Sagittal transvaginal image demonstrates
maximum endometrial thickness of 6 mm (between crosses).
B Sagittal image during HSG demonstrates normal thin endome-
trium. No abnormalities are identified.
Fig. 4. Normal secretory endometrium. A Sagittal view of the
uterus demonstrates hyperechoic secretory endometrium just prior
to the onset of menstrual flow (day 27). The endometrial measure-
ment is denoted between arrowheads. The hypoechoic halo
around the endometrium is at the junction of the endometrium and
myometrium. B Power Doppler image of the myometrium demon-
strates the expected hypervascularity in the secretory phase (ar-
rows).
Fig. 5. Uterus during menstruation. Sagittal image of the uterus to-
ward the end of the menstrual period. The endometrium is thin
(arrows). When measuring the endometrial thickness, the thick-
ness of the fluid must be subtracted.
Abnormal uterine bleeding in premenopause
It is difficult to define the exact cause of abnormal or
irregular uterine bleeding (AUB) in the premenopausal
patient, but pathologic conditions of the endometrium
or myometrium often are factors. Anovulatory cycles
are a common cause, but hyperplasia, polyps, submu-
cous myomas, and carcinoma are possible and of con-
cern to the patient. Clinical procedures often used to
evaluate patients with AUB include D&C and endo-
metrial biopsy (EMB), with hysteroscopy reserved for
complex cases with persistent bleeding [16–18]. Pa-
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Fig. 6. Recent ovulation and corpus luteum formation. A Sagittal im-
age through the uterus demonstrates partially filled bladder (B) ante-
riorly and free intraperitoneal fluid posteriorly (F) due to recent ovu-
lation. The endometrium is hyperechoic, indicating early secretory
phase. B View of the left ovary demonstrates hyperechoic corpus lu-
teum (cl) due to intense hemorrhage following ovulation.
Fig. 7. Normal secretory endometrium in postmenopausal patient on
cyclic HRT. A Transvaginal scan in the sagittal plane demonstrates
mildly thickened endometrium (12.4 mm) identified between the
curser marks. Endometrial measurement was difficult in this patient.
B HSG demonstrates mildly prominent endometrium without other
pathology. D&C demonstrated secretory endometrium. Echoes from
the catheter are seen in the lower uterine segment (arrows).
Fig. 8. Endometrial polyp with normal endometrium on TVS. A Post-
menopausal patient with bleeding. TVS demonstrates very thin en-
dometrium. B HSG demonstrates small polyp (arrowhead) not visible
on TVS. Multiple echoes in the instilled fluid are air bubbles.
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Table 1. Postmenopausal endometrial thickness (asymptomatic
patient)
Normal hormone status Maximum thickness (mm)
No hormonal replacement 6
Unopposed estrogen 8
Continuous estrogen / progesterone 8
Sequential estrogen / progesterone 15a
8b
a In secretory phase
b In menstrual or proliferative phase
tients with menorrhagia fall into a similar diagnostic
dilemma as those with AUB because submucous leio-
myomas and polyps are causes, as are generalized leio-
myomas with uterine enlargement and adenomyosis.
The value of ultrasound in evaluating and triaging
these patients cannot be overemphasized. TAS may be
indicated in the patient with an enlarged uterus at the
time of physical examination, but TVS and HSG are
critical in the overall evaluation and clinical care of pa-
tients with abnormal bleeding. Although an endometrial
diameter of 4 mm or less excludes most pathology, our
experience suggests that HSG is useful even in patients
with thin endometria (Fig. 8). When HSG is performed
in premenopausal patients, it is best done in the prolif-
erative phase of the cycle. The sonologist should care-
fully evaluate the endometrial texture to search for small
filling defects that can be better evaluated with HSG [16,
19, 20] (Fig. 9).
Although leiomyomata can often be detected and
followed into the endometrium with TVS, HSG pro-
vides a clearer evaluation of the size of the mass and
can help assess whether the patient is a candidate for an
hysteroscopic myomectomy. If the leiomyoma is intra-
cavitary or predominantly submucous, hysteroscopic re-
section is feasible (Fig. 10). If the lesion is predomi-
nantly mural, hysterectomy is the only choice if the
AUB can be attributed to the leiomyoma [16, 17, 21].
Cicinelli et al. [22] suggested a transabdominal ap-
proach to HSG imaging when evaluating leiomyomata.
Another cause of AUB is endometrial hyperplasia.
It is most commonly cystic, but the cysts are micro-
scopic. Adenomatous hyperplasia, the other form, is
sonographically identical in appearance. With TAS,
TVS, and HSG, there is uniform increased endometrial
echogenicity that can also be hypervascular with color
Doppler [1, 2, 7, 17, 23].
Merce et al. [24] described the role of spectral
Doppler in the evaluation of the endometrium in patients
with AUB. As with other Doppler evaluations attempt-
ing to separate benign from malignant histologies, the
positive predictive value is poor and the information
does not influence the eventual diagnostic or therapeutic
outcome. Others have used uterine artery waveforms to
assess endometrial pathology and have found some suc-
cess in the evaluation of the resistive index in separating
cancer from benign disorders [25]. We have not used
this technique and feel as Granberg and Bourne [4, 15]
that it does not add significantly to the specificity ob-
tained with HSG or change clinical management of the
patient.
Postmenopausal bleeding
Any postmenopausal patient who is not scheduled to
bleed from HRT suffers from postmenopausal bleeding
(PMB) and should have a diagnostic evaluation. The
obvious fear in this patient population is endometrial
cancer. In the past, diagnostic tests such as EMB,
D&C, hysteroscopy, and even hysterectomy were used
to allay the fear of cancer. Even though endometrial
atrophy is the most common cause of PMB and cancer
is only seen in about 10% of patients with PMB, de-
fining the absence of significant pathology is important
in this patient population [26]. Finding less significant
but treatable abnormalities, such as an endometrial
polyp, is important for the psychological health of the
patient. In addition, endometrial polyps may be asso-
ciated with or progress to endometrial cancer, and pol-
ypectomy accompanied by D&C may be indicated in
these patients [27].
Ultrasound has a definite role in the evaluation of
patients with PMB. Conventional diagnostic procedures
have significant false-negative rates for the common
conditions such as polyp, leiomyoma, and cancer [15].
Even though hysteroscopy performed in the office can
be cost-effective in defining the etiology of PMB, pol-
ypectomy and directed biopsy is difficult with this in-
strument and most gynecologists are reluctant to per-
form this uncomfortable procedure in an office setting.
We have begun to study every patient with PMB
with TVS followed by HSG. Our experience has been
that using TVS alone cannot define all of the abnor-
malities and that normal thickness endometria can har-
bor polyps or submucous leiomyomata (Figs. 8, 9, 11).
Furthermore, defining a thickened endometrium does
little to determine the etiology, and many polyps appear
as a thickened endometrium at first glance (Fig. 12).
However, in the multicenter ‘‘Nordic Trial,’’ 35% of
women with PMB with endometrial thicknesses of 6–
10 mm had atrophic endometria histologically [28]
(Figs. 3, 7).
Several features favor an endometrial polyp with
TVS and confirm the presence of a polyp with HSG.
Cystic spaces in the endometrium are characteristic of
polyps [29–32]. The spaces may represent dilated
glands seen histologically (Fig. 13). Polyps tend to be
on a thin stalk and with color Doppler have a single
vessel entering the stalk [6] (Figs. 8, 9, 12). The vas-
cularity of a polyp is less than that of a pedunculated
submucous leiomyoma, which can be mistaken for a
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Fig. 9. Perimenopausal patient with endometrial polyp. A Sagittal TVS
demonstrates mild uterine enlargement with 5 mm endometrium and
heterogenous echo pattern, suggesting a polyp. B Gray-scale image
during HSG demonstrates endometrial polyp (arrow) with otherwise
normal endometrium. C Power Doppler image demonstrates single
vessel entering the stalk of the polyp (arrow), a common feature of
endometrial polyps.
Fig. 10. Perimenopausal woman with abnormal uterine bleeding and
submucous leiomyoma. Image in the transverse plane from HSG dem-
onstrates large submucous leiomyoma (L), filling almost 50% of the
endometrial cavity at this level.
polyp with HSG (Fig. 14). Polyps may be multiple, and
careful search for others is necessary when a large polyp
is initially discovered (Fig. 12). Polyps are typically
echogenic with TVS and with HSG, although they are
occasionally hypoechoic with TVS. The increased
echogenicity with HSG is related to the differential
echodensity with the surrounding fluid and to acoustic
enhancement (Fig. 9).
Submucous leiomyomata are a cause of PMB.
Leiomyomata are often inhomogeneous with mixed
echogenicity, and they disrupt the endometrium [6, 7].
When a leiomyoma is large and has continuity with the
myometrium, the distinction from a polyp or carcinoma
is easy (Figs. 10, 14). Occasionally, a submucous leio-
myoma is pedunculated and mimics the appearance of
a polyp. In this instance, differentiation is more difficult
(Figs. 11, 15). Features suggesting leiomyoma include
a broader base, irregular shape, and increased vascular-
ity with color Doppler (Figs. 11, 14, 15). Our experience
suggests that the pedunculated polyplike leiomyomata
are more commonly the cause of PMB than the larger
lesions connected to the myometrium.
As in the premenopausal woman, detection and
staging of submucous leiomyomata can be useful in
the preoperative decision of hysteroscopic versus
open treatment of the lesion depending on the size and
percentage of protrusion into the endometrial cavity.
HSG is an ideal procedure to provide that information
[21, 22].
Although not a cause of bleeding, uterine adhesions
or synechiae have been discovered in patients with
PMB. Adhesions are probably the result of previous
uterine instrumentation and are associated with infertil-
ity in premenopausal women [6, 7] (Fig. 16). In addi-
tion, linear bands may be remnants of hemorrhage and
only represent fibrin strands when they are seen shortly
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Fig. 11. Polypoid submucous leiomyoma. A patient with postmeno-
pausal bleeding. An initial TVS showed a thin endometrium. HSG
demonstrates small irregular polypoid mass subsequently proven to
be submucous leiomyoma. These can be extremely difficult to separate
from denomatous polyps.
Fig. 12. Endometrial polyp mimicking thickened endometrium. A Pa-
tient with postmenopausal bleeding demonstrates thickened endome-
trium on TVS. B HSG demonstrates one large and one small polyp
with normal endometrium. The apparent thickened endome-
trium was the large polyp. C Power Doppler image demonstrates rel-
atively hypovascular appearance of the polyp with a single vessel
emanating from the stalk.
Fig. 13. Tamoxifen induced polyp with cystic spaces. A TVS dem-
onstrates enlarged hyperechoic endometrium with central hypoechoic
region (arrow). B Sagittal image during HSG illustrates the presence
of a large polyp causing the apparent thickened endometrium. The
hypoechoic region is a cystic space.
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Fig. 14. Endometrial polyp and submucous leiomyoma in postmenopausal
bleeder. A TVS shows poor visualization of the endometrium, which is
irregular and inhomogeneous. B Transverse image of HSG demonstrates
well-defined polyp (p) with narrow stalk. The edge of a leiomyoma (L)
is seen on the same image. C Transverse image through a different plane
demonstrates hypoechoic leiomyoma (L) protruding into the endometrial
cavity. D Power Doppler image demonstrates polyp and leiomyoma. The
polyp is hypovascular and the leiomyoma is hypervascular.
Fig. 15. Submucous leiomyoma mimicking polyp. A Patient with post-
menopausal bleeding and largely intraluminal filling defect looking
like a polyp on the transverse plane. B Sagittal image demonstrates
broader base to the intraluminal mass, with apparent continuity from
the myometrium, suggesting a leiomyoma.
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Fig. 16. Uterine synechia. Bright linear echo seen during HSG on patient
with postmenopausal bleeding is a synechia (arrow). The patient had
had no recent instrumentation, making a fibrin strand unlikely.
Fig. 17. Endometrial cancer in patient with postmenopausal bleeding.
A Sagittal image from TVS shows poorly defined thickened endo-
metrium with inhomogeneity. B Transverse image from TVS shows
very thick endometrium, with inhomogeneity consistent with endo-
metrial cancer. C Transverse image during HSG demonstrates poor
filling of the endometrial cavity due to large endometrial mass. The
carcinoma extends deep into the myometrium (arrows).
Fig. 18. Endometrial cancer. A broad-based polypoid mass is seen
protruding into the endometrial cavity. This mass proved to be an
endometrial cancer. (Courtesy of Marcella Bohm-Velez, Pittsburgh,
PA)
Fig. 19. Pyometra. Transabdominal ultrasound performed on post-
menopausal patient with vague pelvic pain demonstrated large fluid
collection filling the endometrium with very thin myometrium, which
proved to be a pyometra secondary to cervical stenosis.
Fig. 20. Tamoxifen changes in the subendometrium. Breast cancer
patient with long-standing tamoxifen therapy. Postmenopausal bleed-
ing was evaluated with ultrasound, demonstrating cystic changes.
HSG was not performed. D&C yielded scant atrophic tissue. Cystic
changes are presumed due to subendometrial adenomyosis.
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after EMB, a common scenario for this patient popu-
lation. To decrease the incidence of false-positive sy-
nechiae, we usually wait at least 1 week after EMB prior
to performance of HSG.
Exclusion of endometrial cancer is the goal of eval-
uating the patient with PMB. As a result, evaluation
with ultrasound, Doppler, or HSG is only ancillary to a
definitive biopsy either in the office or in the operating
room [33–36]. However, TVS demonstration of an en-
dometrial thickness of 4 mm or less virtually excludes
carcinoma with the same reliability as an EMB plus
D&C. When TVS demonstrates a thin endometrium and
the question asked is strictly related to presence or ab-
sence of cancer, biopsy is not necessary; in the Nordic
Trial, the number of biopsies was decreased by 46%
without loss of accuracy [28]. If an EMB is inadequate,
as happens frequently, TVS with or without HSG can
be used to determine if the inadequate tissue sample is
due to endometrial atrophy or to a technical failure re-
quiring further evaluation with D&C and hysteroscopy.
In cases where the bleeding is sufficiently distressing to
the patient, HSG should be done, with definitive therapy
planned accordingly.
The appearance of endometrial cancer with TVS and
HSG is well described. With TVS, the endometrium is
diffusely thickened, irregular, and echogenic [1, 2] (Fig.
17). Uncommonly, endometrial cancer is a broad-based
polypoid mass [1] (Fig. 18). Ultrasound has been ad-
vocated for assessing myometrial invasion by endome-
trial cancer [31, 32, 37–39]. Superficial invasion is
associated with the preservation of the subendometrial
halo, whereas deep invasion is associated with loss of
the halo [38].
Endometrial fluid
The incidental finding of fluid in the endometrial cavity
is less ominous during premenopause than during post-
menopause. In the presence of bleeding, fluid can often
be seen. In the absence of bleeding during postmeno-
pause, a fluid collection is often the result of cervical
stenosis and can be due to any of the previously de-
scribed etiologies of bleeding, although some series
have suggested a very low incidence of cancer [4, 32,
40]. Unfortunately, it is often impossible to perform an
EMB or even to perform D&C and hysteroscopy with-
out a major surgical procedure to dilate the cervix.
One of the complications of long-standing fluid in
the endometrial cavity is infection leading to pyometra
(Fig. 19), which often leads to hysterectomy. Ultra-
sound can be useful to discover the etiology of the fluid
and to guide surgical or radiologic aspiration of the
fluid.
Tamoxifen-related abnormalities
Tamoxifen is a commonly used drug for adjuvant treat-
ment of breast cancer in postmenopausal women and
is also being investigated for prophylaxis against breast
cancer. The hormone has estrogenic and antiestrogenic
effects and is the cause of endometrial and subendo-
metrial abnormalities. Bleeding is common, but ab-
normalities are seen in the absence of bleeding. Screen-
ing for tamoxifen changes in the uterus may be
indicated [41].
Tamoxifen can lead to endometrial hyperplasia, car-
cinoma, and cystic subendometrial changes, which may
be due to adenomyosis [42–44]. Tamoxifen is associ-
ated with an increased incidence of endometrial polyps;
as a consequence, when cystic changes are identified in
a thickened endometrium in patients on tamoxifen, HSG
is necessary to define the pathology and guide further
diagnosis and therapy [45–47]. When a polyp is iden-
tified, hysteroscopic removal is indicated (Fig. 13).
When hyperplasia or carcinoma is suggested, EMB or
D&C should be done. If the changes are all subendo-
metrial, no biopsy is necessary (Fig. 20).
Conclusions
Modern gynecologic ultrasound has revolutionized the
evaluation of women with common endometrial-related
problems previously relegated to blind and inaccurate
diagnostic procedures. The development and increasing
popularity of HSG has led to increased understanding
of the endometrium seen with TVS. It is now possible
for the experienced sonologist to examine the endo-
metrium with TVS and predict normality or abnormality
and identify polyps, leiomyomata, or carcinoma. This
possibility does not preclude performance of HSG, a
safe, effective, and simple procedure, but it does provide
for greater confidence in the results of TVS when HSG
is contraindicated or not possible because of cervical
stenosis.
With high-resolution TVS and HSG, we have de-
veloped an understanding of the normal endometrium
and the normal variations with the various forms of
HRT. In the presence of abnormal uterine bleeding,
TVS and HSG will provide important information for
accurate diagnosis and therapy in a large population of
patients.
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